Screener
Zoetis ZTS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| International | $1.17B+8.1% | $1.15B+16.6% | $1.12B+7.9% | $1.06B+3.3% | $1.09B+4.8% | |
| U.S. | $1.27B-6.6% | $1.09B-7.9% | $1.24B-1.7% | $1.32B-1.8% | $1.36B+3.7% | |
| Revenue by Product | ||||||
| Animal health diagnostics | $123M+11.8% | $117M+12.5% | $111M+11.0% | $110M+8.9% | $110M+6.8% | |
| Anti-infectives | $244M+9.9% | $241M+1.3% | $284M+1.1% | $284M+3.6% | $222M-15.9% | |
| Cattle | $390M+20.7% | $392M+15.0% | $415M+4.0% | $399M+2.0% | $323M-7.7% | |
| Contract manufacturing & human health | $29M-12.1% | $23M-23.3% | $30M+42.9% | $23M+9.5% | $33M+83.3% | |
| Dermatology | $398M-15.9% | $349M-7.9% | $429M+1.9% | $472M+4.2% | $473M+13.2% | |
| Dogs and Cats | $1.63B-4.9% | $1.44B-2.3% | —— | $1.59B+2.3% | $1.72B+8.7% | |
| Fish | $83M+2.5% | $66M+20.0% | $81M+24.6% | $78M+11.4% | $81M+30.6% | |
| Horses | $74M+4.2% | $76M+18.8% | $6.08B+4.8% | $66M+13.8% | $71M+4.4% | |
| Other Non Pharmaceuticals | $70M+2.9% | $66M-7.0% | $70M+7.7% | $64M+3.2% | $68M+4.6% | |
| Other pharmaceutical | $168M-4.0% | $158M0.0% | $188M+4.4% | $178M+5.3% | $175M+14.4% | |
| Pain and sedation | $217M-2.7% | $203M-1.9% | $209M-3.7% | $204M-6.8% | $223M+0.9% | |
| Parasiticides | $698M+5.8% | $586M+2.4% | $542M+4.4% | $564M+6.4% | $660M+10.0% | |
| Poultry | $115M+10.6% | $118M+11.3% | $117M0.0% | $106M-23.7% | $104M-21.2% | |
| Sheep and other | $26M+4.0% | $21M+5.0% | $18M+5.9% | $31M+14.8% | $25M+25.0% | |
| Swine | $117M-0.8% | $123M+17.1% | $125M-2.3% | $111M-15.3% | $118M-9.2% | |
| Vaccines | $521M+2.2% | $519M+18.2% | $512M+10.8% | $496M+6.0% | $510M+14.6% | |
| Revenue by Geography | ||||||
| Australia | $94M+13.3% | $89M+12.7% | $84M+5.0% | $87M+4.8% | $83M0.0% | |
| Brazil | $103M+10.8% | $90M+11.1% | $112M-0.9% | $100M-1.0% | $93M-6.1% | |
| Canada | $72M+1.4% | $73M+4.3% | $80M+6.7% | $70M+6.1% | $71M-5.3% | |
| Chile | $34M0.0% | $38M+8.6% | $40M+33.3% | $29M-6.5% | $34M+9.7% | |
| China | $62M-7.5% | $63M+14.5% | $50M-23.1% | $45M-26.2% | $67M-1.5% | |
| France | $40M-4.8% | $37M-5.1% | $52M+15.6% | $40M+11.1% | $42M+23.5% | |
| Germany | $69M+21.1% | $59M+7.3% | $65M+10.2% | $62M+8.8% | $57M-1.7% | |
| Italy | $40M+8.1% | $39M+30.0% | $35M+2.9% | $35M+12.9% | $37M+2.8% | |
| Japan | $41M-4.7% | $35M+9.4% | $39M+2.6% | $34M+3.0% | $43M+10.3% | |
| Mexico | $47M+20.5% | $48M+37.1% | $44M+10.0% | $41M+5.1% | $39M-15.2% | |
| Other developed markets | $187M+6.9% | $169M+27.1% | $182M+20.5% | $164M+10.8% | $175M+26.8% | |
| Other emerging markets | $269M+20.6% | $291M+22.3% | $212M+8.7% | $228M+3.6% | $223M+0.5% | |
| Spain | $43M+7.5% | $40M+37.9% | $37M+23.3% | $38M+8.6% | $40M+21.2% | |
| Total geographical area | $2.44B-0.1% | $2.24B+3.3% | $2.36B+2.7% | $2.38B+0.4% | $2.44B+4.2% | |
| United Kingdom | $72M-11.1% | $78M+5.4% | $89M+6.0% | $82M+2.5% | $81M+11.0% | |
| United States | $1.27B-6.6% | $1.09B-7.9% | $1.24B-1.7% | $1.32B-1.8% | $1.36B+3.7% |
FAQ
- How does Zoetis break its business down?
- Zoetis (ZTS) reports revenue by business across 2 parts — International and U.S.. Each is extracted from the segment footnotes and tracked over time.
- Where does Zoetis's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Zoetis's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
